In the rapidly evolving industry of contract development and manufacturing organizations (CDMOs), a well-defined pricing strategy is essential to drive growth and profitability. To stay ahead and participate in the expansion of the market, CDMOs need to transition to a structured value-based pricing approach that considers customer value, complexity, and specific needs.
At the end of the third quarter, the chemical industry continues to face an economic slowdown, compounded by international trade conflicts, increased political uncertainty, and fundamental changes to the value chain (e. g. the case of electro-mobility.)
Outsourcing product development and manufacturing has become for many pharmaceutical and biotech companies a strategic activity and an integral part of their business model.
A study themed "Sales excellence - Boost your sales power" conducted by Simon-Kucher & Partners together with CHEManager International reveals that chemical companies focus their sales activities primarily on the goals of either boosting profits or acquiring new customers.
Business success largely depends on the quality of sales. The vast majority of companies rightly regard their sales power as their key to success in international competition.
Before the economic crisis, raw material prices knew only one direction: upwards. The sky seemed to be the limit.
